These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35796269)

  • 1. [
    Oh M; Oh JS; Oh SJ; Lee SJ; Roh JH; Kim WR; Seo HE; Kang JM; Seo SW; Lee JH; Na DL; Noh Y; Kim JS
    J Clin Neurol; 2022 Jul; 18(4):437-446. PubMed ID: 35796269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau PET With
    Huang CC; Hsiao IT; Huang CY; Weng YC; Huang KL; Liu CH; Chang TY; Wu HC; Yen TC; Lin KJ
    Front Neurol; 2019; 10():503. PubMed ID: 31191427
    [No Abstract]   [Full Text] [Related]  

  • 3. Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
    Park JE; Yun J; Kim SJ; Shim WH; Oh JS; Oh M; Roh JH; Seo SW; Oh SJ; Kim JS
    PLoS One; 2019; 14(12):e0226265. PubMed ID: 31834916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
    Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
    J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Heterogeneous Subtypes of Mild Cognitive Impairment Using Cluster Analyses Based on PET Imaging of Tau and Astrogliosis.
    Lee HJ; Lee EC; Seo S; Ko KP; Kang JM; Kim WR; Seo HE; Lee SY; Lee YB; Park KH; Yeon BK; Okamura N; Na DL; Seong JK; Noh Y
    Front Aging Neurosci; 2020; 12():615467. PubMed ID: 33584247
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.
    Chételat G; Ossenkoppele R; Villemagne VL; Perrotin A; Landeau B; Mézenge F; Jagust WJ; Dore V; Miller BL; Egret S; Seeley WW; van der Flier WM; La Joie R; Ames D; van Berckel BN; Scheltens P; Barkhof F; Rowe CC; Masters CL; de La Sayette V; Bouwman F; Rabinovici GD
    Brain; 2016 Sep; 139(Pt 9):2528-39. PubMed ID: 27357349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of ischemic stroke-related changes on
    Huang KL; Hsu JL; Lin KJ; Chang CH; Wu YM; Chang TY; Chang YJ; Liu CH; Ho MY; Wey SP; Yen TC; Okamura N; Hsiao IT; Lee TH
    EJNMMI Res; 2018 Jul; 8(1):62. PubMed ID: 30014313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in gray and white matter
    Son HJ; Oh JS; Roh JH; Seo SW; Oh M; Lee SJ; Oh SJ; Kim JS
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):357-366. PubMed ID: 30109402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
    J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Nam G; Jeong HJ; Kang JM; Lee SY; Seo S; Seo HE; Park KH; Yeon BK; Ido T; Shin DJ; Noh Y
    Dement Neurocogn Disord; 2018 Dec; 17(4):163-173. PubMed ID: 30906406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.
    Harada R; Okamura N; Furumoto S; Tago T; Maruyama M; Higuchi M; Yoshikawa T; Arai H; Iwata R; Kudo Y; Yanai K
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):125-32. PubMed ID: 23100049
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Park S; Oh M; Kim JS; Lee JH; Yoon YW; Roh JH
    Brain Sci; 2021 Apr; 11(4):. PubMed ID: 33917613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
    Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O;
    Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type.
    Lagarde J; Olivieri P; Tonietto M; Gervais P; Comtat C; Caillé F; Bottlaender M; Sarazin M
    Transl Psychiatry; 2021 Sep; 11(1):498. PubMed ID: 34588422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.